SE0200876L - Nässpray mot öroninflammationer - Google Patents

Nässpray mot öroninflammationer

Info

Publication number
SE0200876L
SE0200876L SE0200876A SE0200876A SE0200876L SE 0200876 L SE0200876 L SE 0200876L SE 0200876 A SE0200876 A SE 0200876A SE 0200876 A SE0200876 A SE 0200876A SE 0200876 L SE0200876 L SE 0200876L
Authority
SE
Sweden
Prior art keywords
nasal spray
ear infections
spray against
against ear
medicament
Prior art date
Application number
SE0200876A
Other languages
English (en)
Other versions
SE0200876D0 (sv
Inventor
Krister Tano
Original Assignee
Krister Tano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krister Tano filed Critical Krister Tano
Priority to SE0200876A priority Critical patent/SE0200876L/sv
Publication of SE0200876D0 publication Critical patent/SE0200876D0/sv
Publication of SE0200876L publication Critical patent/SE0200876L/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01001NADH peroxidase (1.11.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
SE0200876A 2002-03-22 2002-03-22 Nässpray mot öroninflammationer SE0200876L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer
AT03745048T AT347370T (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media
DE2003610212 DE60310212T2 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid-produzierenden Enzyms zur Behandlung von Otitis Media
PCT/SE2003/000384 WO2003080109A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
ES03745048T ES2277641T3 (es) 2002-03-22 2003-03-06 Utilizacion de una enzima productora de peroxido de hidrogeno para el tratamiento de otitis media.
AU2003215987A AU2003215987A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
EP20030745048 EP1490096B1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
US10/508,590 US20050238635A1 (en) 2002-03-22 2003-03-06 Use of hyrogen peroxide producting enzyme for treatment of otitis media

Publications (2)

Publication Number Publication Date
SE0200876D0 SE0200876D0 (sv) 2002-03-22
SE0200876L true SE0200876L (sv) 2003-09-23

Family

ID=20287356

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Country Status (8)

Country Link
US (1) US20050238635A1 (sv)
EP (1) EP1490096B1 (sv)
AT (1) AT347370T (sv)
AU (1) AU2003215987A1 (sv)
DE (1) DE60310212T2 (sv)
ES (1) ES2277641T3 (sv)
SE (1) SE0200876L (sv)
WO (1) WO2003080109A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
DK2276505T3 (da) * 2008-03-20 2013-11-25 Krister Tano Næsespray eller næsedråber til behandling af forkølelse

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
IE64353B1 (en) * 1990-02-03 1995-07-26 Boots Co Plc Anti-microbial compositions
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
AU663869B2 (en) * 1991-02-21 1995-10-26 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
SE506529C2 (sv) * 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9708641D0 (en) * 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats

Also Published As

Publication number Publication date
EP1490096A1 (en) 2004-12-29
DE60310212T2 (de) 2007-10-11
US20050238635A1 (en) 2005-10-27
AT347370T (de) 2006-12-15
SE0200876D0 (sv) 2002-03-22
EP1490096B1 (en) 2006-12-06
ES2277641T3 (es) 2007-07-16
WO2003080109A1 (en) 2003-10-02
AU2003215987A1 (en) 2003-10-08
DE60310212D1 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
WO2001001932A3 (en) Oligosaccharide aldonic acids and their topical use
WO2002000167A3 (en) Modified forms of pharmacologically active agents and uses therefor
HRP20040042B1 (hr) Supstituirani oksazolidinoni za kombinacijsku terapiju
RU2004137811A (ru) Композиция для прокладок, раневых повязок и других изделий, контактирующий с кожей
WO2001007432A3 (en) Aminopiperidine derivatives as antibacterials
NO20053742L (no) Tri (cyclo)-substituerte amidforbindelser
RU2003111176A (ru) Новый лекарственный состав на основе растительных компонентов для лечения заболеваний печени и вич-инфекции
AU2001269695A1 (en) Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-based compounds
MXPA01012283A (es) Bencimidazoles sustituidos.
AR002763A1 (es) Dilatador nasal.
CA2380673A1 (en) Compositions comprising modafinil for treatment of attention deficit hyperactivity disorder
AR039269A1 (es) Composiciones farmaceuticas topicas para el tratamiento de las dermatitis
IS2873B (is) 2,4-pýrímídíndíamín gagnleg við meðhöndlun á æxlissjúkdómum, bólgu- og ónæmiskerfiskvillum
NO2007010I2 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
CA2468958A1 (en) Pulmonary delivery of aminoglycosides
SE9803986D0 (sv) New compositions
SE0302923L (sv) Boswellinkompositioner med förhöjd halt av 3-beta-acetyl-11-keto-beta-boswellinsyra ("AKBA"), industriell tillverkning och användningar därav
NZ595193A (en) Modified Proteases That Inhibit Complement Activation
CA2438544A1 (en) Aerosol compositions containing formoterol for delivery to the lungs via nebulization
WO2002072084A3 (en) Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
AR026165A1 (es) Dispositivo para la administracion de drogas.
CA2492976A1 (en) Solution for ungual and peri-ungual application
NO20026196D0 (no) Kinazolinditosylatsalt forbindelser
NO20072906L (no) Metode for forhindring eller behandling av respiratoriske infeksjoner og akutt otitis media hos barn
NO336469B1 (no) Forbindelser med HIV-proteaseaktivitet, farmasøytisk preparat derav og anvendelse derav ved fremstillingen av et medikament for behandling eller forebyggelse av symptomene eller virkningene av HIV-infeksjon.

Legal Events

Date Code Title Description
NAV Patent application has lapsed